BoFA Says Novo Nordisk May Miss Q1 Expectations as Wegovy, Ozempic Sales Lag
GDANSK/LONDON (Reuters) - Bank of America analysts on Friday said Novo Nordisk may miss first-quarter expectations, as sales ...
Is Hims & Hers Health Stock a Smart Buy After Plunging More Than 50%?
Shares of the health and wellness platform operator skyrocketed more than 670% between Jan. 1, 2024, and Feb. 19, 2025.
1 Growth Stock Down 40% to Buy and Hold Forever
And speaking of dividends, Novo Nordisk pays one, and it has increased its annual dividend per share by almost 284% in the ...
Healio19h
FDA recap: First new treatment for stroke in 3 decades, generic rivaroxaban and more
The FDA recently approved the first treatment in nearly 30 years for acute stroke, and the agency also approved a novel drug ...
Exclusive-Trump tariff threats prompt some drugmakers to expedite shipments to US
Concerns about potential pharma tariffs began before Trump took office in January after he threatened universal import tariffs during his campaign. He has since repeatedly threatened a 25% tariff on ...